Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06429384
Status:
COMPLETED
Last Update Posted:
2024-06-04
First Post:
2024-04-03
Brief Title:
Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial
Sponsor:
Beijing Tiantan Hospital
Organization:
Beijing Tiantan Hospital
Organization Data
Organization:
Beijing Tiantan Hospital
Class:
OTHER
Study ID:
Y-3-LC-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beijing Tiantan Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Yongjun Wang
Responsible Party Title:
Chief Physician
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Beijing Tiantan Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| NeuroDawn Pharmaceutical Co Ltd | UNKNOWN |